Literature DB >> 16614661

Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C.

Laurent Castera1, Jean-Michel Pawlotsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16614661      PMCID： PMC1681713     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  49 in total

1.  Pain experienced during percutaneous liver biopsy.

Authors:  L Castéra; I Nègre; K Samii; C Buffet
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

2.  Transforming growth factor-beta 1 in chronic hepatitis C.

Authors:  D R Nelson; R P Gonzalez-Peralta; K Qian; Y Xu; C G Marousis; G L Davis; J Y Lau
Journal:  J Viral Hepat       Date:  1997-01       Impact factor: 3.728

3.  Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis.

Authors:  C Aubé; F Oberti; N Korali; M A Namour; D Loisel; J Y Tanguy; E Valsesia; C Pilette; M C Rousselet; P Bedossa; H Rifflet; M Y Maïga; D Penneau-Fontbonne; C Caron; P Calès
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

4.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

5.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

6.  Noninvasive diagnosis of hepatic fibrosis or cirrhosis.

Authors:  F Oberti; E Valsesia; C Pilette; M C Rousselet; P Bedossa; C Aubé; Y Gallois; H Rifflet; M Y Maïga; D Penneau-Fontbonne; P Calès
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

7.  Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis.

Authors:  Y Murawaki; Y Ikuta; Y Idobe; H Kawasaki
Journal:  J Gastroenterol Hepatol       Date:  1999-02       Impact factor: 4.029

8.  Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.

Authors:  Françoise Imbert-Bismut; Djamila Messous; Vincent Thibault; Vincent Thibaut; Rob B Myers; Annie Piton; Dominique Thabut; Laure Devers; Bernard Hainque; Anne Mercadier; Thierry Poynard
Journal:  Clin Chem Lab Med       Date:  2004-03       Impact factor: 3.694

9.  Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Authors:  Thierry Poynard; Mona Munteanu; Françoise Imbert-Bismut; Frederic Charlotte; Dominique Thabut; Sophie Le Calvez; Djamila Messous; Vincent Thibault; Yves Benhamou; Joseph Moussalli; Vlad Ratziu
Journal:  Clin Chem       Date:  2004-06-10       Impact factor: 8.327

10.  Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

Authors:  Thierry Poynard; John McHutchison; Michael Manns; Rob P Myers; Janice Albrecht
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425
View more
  2 in total

1.  Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound.

Authors:  Trong N Nguyen; Anthony S Podkowa; Alex Y Tam; Eben C Arnold; Rita J Miller; Trevor H Park; Minh N Do; Michael L Oelze
Journal:  Ultrasound Med Biol       Date:  2019-05-08       Impact factor: 2.998

Review 2.  Nonalcoholic fatty liver disease: a review and update.

Authors:  Jeffrey R Lewis; Smruti R Mohanty
Journal:  Dig Dis Sci       Date:  2010-01-26       Impact factor: 3.199
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.